Toxicological effects of ambient fine (PM2.5-0.18) and ultrafine (PM0.18) particles in healthy and diseased 3D organo-typic mucocilary-phenotype models

• Published in: Environmental research 2019-09, Vol.176, p.108538-108538, Article 108538
• Main Authors: Sotty, J., Garçon, G., Denayer, F.-O., Alleman, L.-Y., Saleh, Y., Perdrix, E., Riffault, V., Dubot, P., Lo-Guidice, J.-M., Canivet, L.
• Format: Article
• Language: English
• Subjects: Air Pollutants - toxicity; Bronchi; Epithelial Cells; Fine and ultrafine particles; Healthy and diseased phenotypes; Human bronchial epithelial cells; Humans; Inflammation; Life Sciences; Particle Size; Particulate Matter - toxicity; Phenotype; S100 Proteins; Signaling pathways; Toxicology; Transcriptomic profiling
• ISSN: 0013-9351; 1096-0953
• DOI: 10.1016/j.envres.2019.108538

The knowledge of the underlying mechanisms by which particulate matter (PM) exerts its health effects is still incomplete since it may trigger various symptoms as some persons may be more susceptible than others. Detailed studies realized in more relevant in vitro models are highly needed. Healthy normal human bronchial epithelial (NHBE), asthma-diseased human bronchial epithelial (DHBE), and COPD-DHBE cells, differentiated at the air-liquid interface, were acutely or repeatedly exposed to fine (i.e., PM2.5-0.18, also called FP) and quasi-ultrafine (i.e., PM0.18, also called UFP) particles. Immunofluorescence labelling of pan-cytokeratin, MUC5AC, and ZO-1 confirmed their specific cell-types. Baselines of the inflammatory mediators secreted by all the cells were quite similar. Slight changes of TNFα, IL-1β, IL-6, IL-8, GM-CSF, MCP-1, and/or TGFα, and of H3K9 histone acetylation supported a higher inflammatory response of asthma- and especially COPD-DHBE cells, after exposure to FP and especially UFP. At baseline, 35 differentially expressed genes (DEG) in asthma-DHBE, and 23 DEG in COPD-DHBE, compared to NHBE cells, were reported. They were involved in biological processes implicated in the development of asthma and COPD diseases, such as cellular process (e.g., PLA2G4C, NLRP1, S100A5, MUC1), biological regulation (e.g., CCNE1), developmental process (e.g., WNT10B), and cell component organization and synthesis (e.g., KRT34, COL6A1, COL6A2). In all the FP or UFP-exposed cell models, DEG were also functionally annotated to the chemical metabolic process (e.g., CYP1A1, CYP1B1, CYP1A2) and inflammatory response (e.g., EREG). Another DEG, FGF-1, was only down-regulated in asthma and specially COPD-DHBE cells repeatedly exposed. While RAB37 could help to counteract the down-regulation of FGF-1 in asthma-DHBE cells, the deregulation of FGR, WNT7B, VIPR1, and PPARGC1A could dramatically contribute to make it worse in COPD-DHBE cells. Taken together, these data contributed to support the highest effects of UFP versus FP and highest sensitivity of asthma- and notably COPD-DHBE versus NHBE cells. •Innovative healthy and diseased 3D organo-typic mucocilary-phenotype models.•Experimental strategy of repeated exposures to ambient fine and ultrafine particles.•Better knowledge on the adverse effects of ambient fine and ultrafine particles.•Highest adverse effects of ultrafine vs fine particles.•Highest responsiveness of diseased vs healthy cell models.